X-medics A/S Financials, key figures and credit report
Gross profit 4 196.9 kDKK FY 2025 +47.4% vs 2024
EBIT 2 706.5 kDKK FY 2025 +86.9% vs 2024
Net debt - 573.6 kDKK FY 2025 +23.2% vs 2024
Quick ratio 3.2 FY 2025 +0.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 413.00 | 3 286.30 | 1 800.06 | 2 848.18 | 4 196.94 |
| Employee benefit expenses | -2 119.78 | -3 285.86 | -1 372.20 | -1 400.25 | -1 490.41 |
| EBIT | 293.22 | 0.44 | 427.85 | 1 447.92 | 2 706.53 |
| Other financial income | 30.79 | 54.42 | 35.92 | 17.07 | 36.36 |
| Other financial expenses | -0.36 | -69.11 | -92.70 | -80.77 | -76.00 |
| Reduction non-current investment assets | - 206.05 | ||||
| Pre-tax profit | 117.60 | -14.25 | 371.08 | 1 384.22 | 2 666.89 |
| Income taxes | -25.86 | 2.88 | -81.86 | - 305.60 | - 598.46 |
| Net earnings | 91.74 | -11.37 | 289.21 | 1 078.62 | 2 068.43 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Raw materials and consumables | 557.25 | ||||
| Finished products/goods | 277.50 | 542.00 | 349.12 | 427.24 | 701.28 |
| Inventories total | 277.50 | 542.00 | 349.12 | 427.24 | 1 258.53 |
| Current trade debtors | 691.97 | 711.99 | 358.93 | 805.79 | 1 413.29 |
| Current amounts owed by group member comp. | 259.07 | ||||
| Prepayments and accrued income | 28.00 | ||||
| Current other receivables | 37.32 | 87.52 | 230.59 | 146.44 | 8.36 |
| Current deferred tax assets | 2.88 | ||||
| Short term receivables total | 757.30 | 802.39 | 589.53 | 952.23 | 1 680.72 |
| Cash and bank deposits | 357.91 | 344.57 | 385.46 | 746.89 | 573.67 |
| Cash and cash equivalents | 357.91 | 344.57 | 385.46 | 746.89 | 573.67 |
| Balance sheet total (assets) | 1 392.71 | 1 688.97 | 1 324.11 | 2 126.36 | 3 512.92 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Shares repurchased | 114.40 | 244.00 | 800.00 | 1 800.00 | |
| Retained earnings | -71.86 | 19.89 | - 235.49 | - 746.27 | -1 467.66 |
| Profit of the financial year | 91.74 | -11.37 | 289.21 | 1 078.62 | 2 068.43 |
| Shareholders equity total | 534.29 | 408.52 | 697.73 | 1 532.35 | 2 800.77 |
| Non-current other liabilities | 98.67 | ||||
| Non-current liabilities total | 98.67 | ||||
| Current trade creditors | 377.87 | 662.48 | 490.24 | 230.08 | 266.72 |
| Current owed to participating | 20.37 | 0.10 | 0.10 | 0.10 | 0.10 |
| Short-term deferred tax liabilities | 64.98 | 301.60 | 379.79 | ||
| Other non-interest bearing current liabilities | 361.51 | 617.88 | 71.05 | 62.23 | 65.54 |
| Current liabilities total | 759.75 | 1 280.45 | 626.38 | 594.01 | 712.15 |
| Balance sheet total (liabilities) | 1 392.71 | 1 688.97 | 1 324.11 | 2 126.36 | 3 512.92 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated